NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/22/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4,427.35 mln
Float110 mln
Earnings Date07/30/2026
EPS
1.95
Moderate
P / E
19.25
Moderately valued
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-0.83
Highly suspicious
1-Year Forecast
51.50
Strong upside
Relative Strength
22
/ 100
Significantly lagging
Business Description
Indivior Pharmaceuticals is a global specialty pharmaceutical company focused on helping people recover from opioid addiction and related conditions. Its main products are SUBLOCADE, a once-monthly injectable, and SUBOXONE Film, both of which contain buprenorphine and are widely used to treat opioid use disorder across the United States, Europe, Canada, Australia, and other markets. The company is also working to expand its treatment options through several drugs in clinical development. Headquartered in North Chesterfield, Virginia, Indivior has been operating since 2014.
